Ottawa – From July 1 to September 30, 2026, Health Canada approved 16 new drugs submissions (14 pharmaceuticals, 2 biologics) and 540 new medical devices, including 27 Class IV medical devices, which present the greatest potential risk. During this period, Health Canada also approved 30 generic drugs and 3 biosimilar drugs. 30 generic and 3 biosimilar drugs New and innovator ...
The post New drugs and medical devices authorized in Canada first …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.